DatasetName,KIF13A_S(1274) KIF13A_S(1287) KIF13A_S(1369) KIF13A_S(1371) KIF13A_S(1381) KIF13A_S(1384) KIF13A_S(1441) KIF13A_S(1447) KIF13A_S(1454) KIF13A_S(1460) KIF13A_S(1529) KIF13A_S(1631) KIF13A_S(1644) KIF13A_S(1650) KIF13A_S(1663) KIF13A_S(1679) KIF13A_S(1698) KIF13A_S(1700) KIF13A_S(1705) KIF13A_S(3) KIF13A_S(5) KIF13A_S(6) KIF13A_S(636) KIF13A_T(1372) KIF13A_T(1434) KIF13A_T(1447) KIF13A_T(1526) KIF13A_T(1705) KIF13A_T(407) KIF13A_T(409),KIF13A_S(573) KIF13A_S(574) KIF13A_T(1452)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.5192432445172294,
FSO2013_Ratio M/L normalized Rep3,0.5289904955733723,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5177255137616814,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.5163139701738585,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5223689266651294,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5224671713117554,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.5124590860615481,
RB2022_5_PreEndurance,0.5264721820917171,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5329213130054838,
WZ2023_Pu_010_30min,0.5214849440555629,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.5204528676567345,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.5209216260959624,
KBE2022_Log2_Ex_14_U,0.5213708571915864,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5172865969758768,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.5262343154415903,
PG2020_Intensity 8h_C,0.5191428667170332,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5236904843655035,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5206532596023943,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5150889465398069,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.5176221026345184,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5114722699367102,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5178382955951818,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5189311697163069,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5202234021127058,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5231313732265386,
EJN2021_3_Rest_Basal,0.5237143689740866,
CR2017_Ratio Replicate 1.3,0.5174075692662781,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5227929403805098,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5189664013701394,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5223812534392186,
FSO2013_Ratio H/L normalized Rep2,0.5322938809967579,
WZ2023_Pu_005_20min,0.5220864532943675,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.5212977889261087,
HS2024_9_B_T2,0.5239623779402226,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5208576132933207,
PG2020_Intensity Mock_10h_D,0.518982971053832,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.520886710080555,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5218640323594018,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.514788187043227,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,0.5243148723699043,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.5205234391447024,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5204993991405605,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.523434405936099,
EJN2021_5_Rest_Basal,0.522145840757487,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5270888792558733,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,0.5206123818617147,
CR2017_Ratio Replicate 3,0.5140811426931411,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5202953802667541,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5229734215948116,
RB2022_4_RecoveryEndurance,0.5189697893990114,
RB2022_5_RecoveryEndurance,0.5185329804169941,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5172654623352829,
FSO2013_Ratio H/M normalized Rep2,0.5244420274615609,
RAM2015_Log2 A,0.5240363807061342,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5210639451751878,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5188655985659893,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.5201384646574735,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5331172039348042,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5252276361520251,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5238910886666347,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5233648934284896,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5122843018357854,
FSO2013_Ratio M/L normalized Rep2,0.5266422564437889,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,0.5227301814898494,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5196741093406589,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5005948807398151,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5236126914623901,
EJN2021_4_Rest_Ins,0.524469199434174,
RN2012_H05,0.529879686852882,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5241478110673735,
EJN2021_1_Rest_Ins,0.5128254756399937,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5176845676923569,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5185085056663907,
CK2022_12 200-1,0.5191479786854016,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5209989123783876,
AH2018_TMTMS2_2_N,0.517358452788938,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5157317564038699,
AH2018_TMTMS3_Pool,0.5235228043360286,
KS2014_Intensity N4,0.5274363966975201,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.519364351012141,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5239090449501477,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5156499225862198,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5207101128797704,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.5177024079599963,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5177059886033069,
CF2017_EOC 1,,
CK2022_3 200-1,0.521081488792039,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.5183932464078992,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.5207083948560715,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.5208089357058427,
CK2022_2 40-1,,
RB2022_1_PostSprint,0.5250287896393246,
CK2022_4 200-1,0.5208351425869161,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5042651491850328,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5181252435930788,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5193820768307102,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5185365850579353,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5221755787294566,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.5166511719531875,
AH2018_TMTMS3_3_X,0.5233432405428643,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5216645423799166,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.5254815295153316,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5176396311865662,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5185898999085171,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5225423831952116,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.5224515816789471,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5234292329833975,
SR2019_SKBR3_Biol_repl_3,0.520918579790748,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5253523032351943,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5220245376495826,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.5220593709228355,
AH2018_TMTMS2_3_X,0.516766327193003,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.518922414926536,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5136070634840088,
KBE2022_Log2_Ex_19_U,0.5219355680662524,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.5257140831965667,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5264980191002787,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5285412067503955,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5238483945905273,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.51924768989601,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.5191789410943567,
CR2017_Ratio Replicate 2,0.5221499256445884,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5243668850998984,
AR2021_KD 72h,0.5072169141331125,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5240808023342891,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5233775647233475,
KBE2022_Log2_Ex_9_U,0.5214392167959201,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.5211666079183284,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5220619297074972,
PG2020_Intensity Mock_10h_C,0.5252094356210626,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5220594813745956,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5238915335284732,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5214311691215445,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5202018666470374,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5282247717830536,
RB2022_1_PreSprint,0.5197251067450768,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5200202841592354,
CK2022_5 200-1,0.5201714602147095,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5324542269024982,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.5185069212366767,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5231301112024346,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5191559912329438,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5217672532035562,
FSO2013_Ratio H/L normalized Rep3,0.5333704181093368,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5217470699897694,
AH2018_SILAC_IT_2_N,0.5235942309108929,
AH2018_SILAC_IT_1_X,0.5233287819769956,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.5208652171061404,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.5175893574634064,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5172546748121092,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5212445756025985,
SR2019_HCC1419_Biol_repl_4,0.522404713466823,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.516630154461404,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5208294894911826,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5228175262457702,
WZ2023_Su_025_10min,0.520739915110673,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5228042951869761,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.5181014887881771,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5116487411983734,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5313584949772364,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5187851972021049,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5167970010120236,
RN2012_L10,0.5224710809223309,
PG2020_Intensity 4h_C,0.5083988490785526,
EP2017_Mitotic R#3 normalized log2 ratio,0.5181671043289313,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,0.5207068995378938,
AH2018_SILAC_IT_2_X,0.5233468268812743,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.527413902969425,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5222641722423816,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5175453708254807,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5195017716716459,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5225798433685026,
GF2025_P9_Sph,,
CK2022_6 200-1,0.5199170111368807,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5237523457836643,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5203886304918413,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5274417944598256,
EP2017_Untreated R#3 normalized log2 ratio,0.5226239352100731,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5199241310249404,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5113105849707879,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5211293568840325,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5157530391968553,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.5225099916786247,
EJN2021_1_Ex_Basal,0.5202036684887763,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5258053818339624,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5228149907229289,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.5204460406992402,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5239645670004449,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.5242768502772365,
CR2017_Ratio Replicate 2.3,0.5259177930894626,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5216293128762831,
CK2022_2 16-1,,
RAM2015_Log2 B,0.519073698327872,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5224428698177395,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5161124703543857,
UK2020_HCM_5,0.5214920250534014,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5247305021461428,
WZ2023_Su_025_30min,0.5206495152619264,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5184425542948403,
HS2024_8_I_N1,0.5250812374935901,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5189328926539358,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.5245147018585439,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5244368785884924,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.5181589539745451,
KS2014_Intensity C5,0.532075166395764,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.5274476362572964,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,0.5195944807795013,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5183377051431332,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.5266819921302363,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.5263017176323136,
KS2014_Intensity E15_3,0.5214726382230207,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.517735865794354,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5214786304089986,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5235964706414487,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.5193367808715916,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5221240443499245,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5191816496305731,
UK2020_UA_1,0.5215207416144013,
KBE2022_Log2_Ex_13_U,0.5244069873948409,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5169884913115873,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5255686721557008,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5147778756513465,
HS2024_5_PD_T2,0.5183447376624334,
WZ2023_Su_025_20min,0.5217128118703342,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.521882509513936,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5210388281021652,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.519260111669123,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5243385486323554,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5184479288257655,
EP2017_Pervanadate R#3 log2 ratio,0.5145640922581403,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.5222248944185404,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5178371261629067,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5240111235993535,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5197612466124583,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5178882331997609,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5213641873358423,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5219194310390632,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5212162625869747,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,0.5176380136160305,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5264651163327323,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5174670030448641,
RB2022_4_PreSprint,0.5225933140268875,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5235619923015643,
HS2024_8_I_N2,0.5262251446042305,
RB2022_3_RecoveryStrength,0.522997820535966,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5183754140339509,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.5142145849740541,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5171637584913705,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.5174081524076085,
AH2018_LFQ_IT_1_X,0.5186573439652308,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.5204474338543742,
WZ2023_Pe_005_20min,0.5187409847738869,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5227768006185675,
AH2018_TMTMS3_3_N,0.5235055175317643,
SR2019_HCC1419_Biol_repl_2,0.5223224965142416,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5185793414479792,
KBE2022_Log2_Ex_36_T,0.5228722126798032,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5211877970389475,
KS2014_Intensity C2,0.529388987648516,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5188417692104377,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5187764359799497,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5158745311949615,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5152621230310509,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5233825680521959,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5169055222248761,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5216151182070367,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.520050379970375,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5302044140654057,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5251838418444658,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5220579196072562,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5216636805295437,
HS2024_5_B_N2,0.5159957335780192,
HS2024_5_I_N1,0.5161254489539782,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5095262804118972,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.5230343083204099,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.5200716715988166,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.518986262281607,
KBE2022_Log2_Ex_29_U,0.5210154560834437,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5196149795986436,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5216588201224834,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5207247089033049,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5212815997870234,
RN2012_H01,0.5142199357305368,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5185645511043073,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5122081677416062,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.5176632137895801,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.5242466587981665,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5350483658273082,
FSO2013_Ratio H/M normalized Rep3___1,0.5244157306384591,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.521579741203468,
PG2020_Intensity 6h_C,0.5195251622485614,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5175859656268201,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5188003995873145,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5269425716085421,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.5214693526189739,
SAS2015_AZD/DMSO_Exp2,0.5258265046257977,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5193342342807062,
EJN2021_2_Ex_Basal,0.5163216075157111,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5278655540689207,
CF2017_EOC 2,,
RB2022_6_PostEndurance,0.5245333039326135,
AH2018_SILAC_1_N,0.5172678690306153,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.5204166764846498,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.5194786885558471,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5176258169449752,
AR2021_L41 1 μM,0.5312081950919739,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5186314421514758,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5289634411838761,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.520717841042175,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5199100519646158,
AH2018_SILAC_IT_3_C,0.5168747755078981,
WZ2023_Pu_025_10min,0.5192981037772383,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5287808898441559,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5176496364777352,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5279929147417769,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5182096412378412,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,0.519905645593857,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,0.5264230169428846,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5335587040953926,
SR2019_HCC1954_Biol_repl_3,0.5183115067372507,
CR2017_Ratio Replicate 2.2,0.5296084809638752,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.519770624547154,
PG2020_Intensity CT_B,0.5238371407612656,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5251529404924881,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.521088817290591,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5188186735908527,
AH2018_TMTMS2_1_X,0.5183690055787592,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5145635179522073,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.518657811918585,
PG2020_Intensity 10h_B,0.513880452024242,
AH2018_TMTMS3_1_X,0.5241795673437435,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5207386699242414,
SR2019_HCC1419_Biol_repl_3,0.5221684698405563,
KBE2022_Log2_Ex_14_T,0.5224813876772072,
EP2017_Untreated R#2 normalized log2 ratio,0.5191058801186108,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5207995561791933,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5106100371853236,
AS2011_Ratio H/L Normalized RNAi_2_1,,
